Filomena Napolitano | Immunology and Microbiology | Innovative Research Award

Innovative Research Award

Filomena Napolitano — University of Naples Federico II

Filomena Napolitano
Affiliation University of Naples Federico II
Country Italy
Scopus ID 57201650666
Documents 30
Citations 395
h-index 13
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0003-1925-9912

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II, Italy, whose stated subject area is Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, providing quantitative indicators of the scholarly record associated with the identified author profile. [1]

This academic recognition page presents the available research information in relation to the Innovative Research Award under the World Science Awards. The profile combines bibliographic indicators with a qualitative discussion of research contribution, publication activity, and potential award relevance while avoiding conclusions that cannot be established from the supplied data alone. [3]

Abstract

Filomena Napolitano is a researcher associated with the University of Naples Federico II in Italy and identified within the broad subject area of Immunology and Microbiology. The supplied bibliometric information records 30 documents, 395 citations, and an h-index of 13. [1] These indicators provide a quantitative description of the scholarly record represented by the identified Scopus author profile. The researcher is considered in connection with the Innovative Research Award of the World Science Awards, with the available evidence supporting an assessment of research activity and scholarly visibility while recognizing that bibliometric measures alone do not establish research quality or innovation.

Keywords

  • Innovative Research Award
  • Filomena Napolitano
  • Immunology
  • Microbiology
  • Immunology and Microbiology Research
  • Pharmaceutical and Biomedical Research
  • Research Impact
  • University of Naples Federico II
  • World Science Awards

Introduction

Immunology and Microbiology encompass interconnected areas of biomedical science concerned with immune responses, infectious organisms, host–microbe interactions, disease mechanisms, diagnostics, therapeutics, and related biological processes. Research across these fields contributes to understanding health and disease and can support the development of new scientific approaches in medicine and biotechnology.

Within this academic context, Filomena Napolitano is identified with the University of Naples Federico II in Italy. The supplied Scopus record reports 30 documents, 395 citations, and an h-index of 13. [1] These values provide a snapshot of publication and citation activity associated with the identified author profile, while the researcher’s ORCID identifier, 0000-0003-1925-9912, provides a persistent identifier for scholarly attribution. [2]

Research Profile

The available profile information places Filomena Napolitano within Immunology and Microbiology and identifies the University of Naples Federico II as the institutional affiliation. The supplied Scopus author identifier is 57201650666. [1] The ORCID identifier is 0000-0003-1925-9912, which can assist in distinguishing the researcher’s scholarly output from that of other authors with similar names. [2]

Bibliometric indicators should be interpreted alongside the disciplinary context, publication chronology, authorship structure, journal characteristics, and research objectives represented in individual studies. Accordingly, the reported metrics provide useful descriptive information but should not be considered a comprehensive assessment of scientific originality, methodological rigor, or practical significance.

Research Contributions

The supplied information identifies Immunology and Microbiology as the principal subject area associated with Filomena Napolitano. Research in this domain can address fundamental and applied questions involving immune regulation, microorganisms, host–pathogen relationships, cellular responses, molecular mechanisms, disease processes, and the development of diagnostic or therapeutic strategies. The specific contributions of an individual researcher should be established through publication-level evidence rather than inferred solely from aggregate bibliometric measures.

  • A documented scholarly record comprising 30 reported documents.
  • A reported citation count of 395 associated with the supplied Scopus profile.
  • An h-index of 13 in the supplied bibliometric record.
  • Research affiliation with the University of Naples Federico II.
  • Academic positioning within Immunology and Microbiology.
  • A persistent ORCID identifier supporting researcher identity and publication attribution.

A fuller evaluation of research contribution would consider the originality of the research questions, methodological quality, reproducibility, interdisciplinary collaboration, contribution to knowledge, and evidence of application or influence within the relevant scientific community.

Publications

The supplied Scopus information reports 30 documents associated with Filomena Napolitano’s author profile. [1] The provided input does not include individual publication titles, journal details, publication dates, article types, or verified DOI identifiers. Consequently, specific publications and DOI records are not attributed here without direct publication-level verification.

The complete publication record may be examined through the researcher’s Scopus author profile and ORCID record. Scopus provides bibliographic and citation information, while ORCID provides persistent researcher identification and can connect scholarly works with the appropriate researcher record. [1] [2]

No publication-specific DOI has been supplied in the source information for this article. Where individual publications are subsequently verified, their DOI records can be incorporated using persistent DOI links such as https://doi.org/.

Research Impact

The supplied bibliometric record contains 395 citations across 30 documents. Based on these reported values, the citation-to-document ratio is approximately 13.2 citations per document. The profile also reports an h-index of 13, indicating that the indexed record contains at least 13 publications that have each received at least 13 citations under the relevant counting conditions. [1]

Citation measures can provide evidence of scholarly visibility, but citation practices differ across fields, publication types, research communities, and publication periods. For this reason, citation count and h-index should be interpreted together with the substance of the research, the significance of individual findings, methodological quality, collaboration, and evidence of influence beyond citation activity.

Award Suitability

The Innovative Research Award associated with the World Science Awards provides a context for recognizing research activity and scientific contributions. [3] Based on the supplied information, Filomena Napolitano has a documented research profile in Immunology and Microbiology, an affiliation with the University of Naples Federico II, 30 reported documents, 395 citations, and an h-index of 13. [1]

These indicators provide relevant quantitative evidence for an academic recognition profile. The ORCID record further provides a persistent scholarly identifier for the researcher. [2] Nevertheless, final award suitability should be determined using the official award criteria together with verified publication records, research originality, scientific contribution, methodological strength, academic development, and supporting evidence.

  1. Review the verified publication record and research outputs associated with the researcher.
  2. Assess originality, scientific relevance, methodological quality, and contribution to Immunology and Microbiology.
  3. Consider citation and other bibliometric indicators as supporting evidence rather than as the sole basis for evaluation.
  4. Apply the official World Science Awards evaluation criteria to determine final award eligibility and recognition.

Conclusion

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II in Italy and associated with the field of Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, while the ORCID identifier 0000-0003-1925-9912 provides a persistent identifier for the researcher’s scholarly identity. [1] [2]

The available information establishes a substantive bibliometric profile that may be considered in connection with the Innovative Research Award. A complete recognition decision should nevertheless incorporate verified research outputs and qualitative evidence of innovation, originality, scientific contribution, and research significance, alongside the official criteria of the World Science Awards. [3]

References

    1. Elsevier. (n.d.). Scopus author details: Filomena Napolitano, Author ID 57201650666. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57201650666

Bulti Kumera | Immunology and Microbiology | Best Academic Researcher Award

Mr. Bulti Kumera | Immunology and Microbiology | Best Academic Researcher Award

Injibara University | Ethiopia

Bulti Kumera Fufa is an Assistant Professor of Microbiology at Injibara University, Ethiopia, with more than a decade of academic and research experience in microbiology and food safety. He holds an MSc in Microbiology from Hawassa University and a BSc in Biology from Debre Berhan University. His research expertise spans food and water microbiology, antimicrobial resistance, mycotoxins, bioremediation, mushroom cultivation, and biofertilizers. He has authored and co-authored nine peer-reviewed journal articles, including publications in Microbiology Open, Discover Applied Sciences, Journal of Water and Health, and BioMed Research International, and currently has additional work under review. Dr. Fufa has served as a principal investigator on applied research projects addressing agricultural waste utilization and antimicrobial properties of natural products. His work contributes directly to public health improvement, food safety assurance, environmental sustainability, and community awareness in Ethiopia through interdisciplinary collaboration and evidence-based research.

Citation Metrics (Scopus)

2015

10
5
0

Citations
16
h-index
2
Documents
7

Citations

h-index

Documents

Scopus Profile
ORCID iD

 

Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Dr. Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Department of Bacterial Diseases of Animals, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Dr. Alireza Dehnad is an accomplished microbiologist and biotechnology researcher whose career spans over twenty-five years of impactful scientific work in veterinary microbiology, microbial biotechnology, and infectious disease research. With 88 Scopus-indexed publications, 2,503 citations, and an h-index of 27, he has demonstrated a consistent record of scholarly excellence, research productivity, and international recognition. His work encompasses diverse domains including microbial bioprocessing, secondary metabolite discovery, nanobiotechnology, antibiotic-producing Actinomycetes, viral and bacterial disease epidemiology, probiotics, wound healing applications, biopolymers for drug delivery, and microbial bioremediation. A major strength of Dr. Dehnad’s scientific career is his ability to bridge fundamental microbiology with translational biotechnology, generating research outputs that extend from laboratory innovation to real-world applications in human health, veterinary medicine, agriculture, and industrial biotechnology. He has contributed to notable advances in green nanoparticle synthesis, microbial metabolite-based therapeutics, pathogen surveillance, and probiotic industrialization. His experience supervising over 100 postgraduate theses and lecturing internationally reflects strong academic leadership, mentorship capacity, and global collaboration. Dr. Dehnad has earned prestigious national awards in recognition of his research contributions, including honors from the Razi Vaccine and Serum Research Institute and the Agricultural Biotechnology Research Institute. His leadership roles across scientific institutions, advisory committees, and biotechnology laboratories demonstrate institutional influence and commitment to advancing regional and national scientific infrastructure. While his research output is internationally visible and diverse, areas for continued development include expanding multi-center global collaborations, strengthening cross-disciplinary publications in high-impact journals, and increasing patent commercialization and industrial partnerships to further translate research outcomes into market-ready solutions.

Profiles: Scopus | ORCID

Featured Publications

Mahmoudi, F., Baradaran, B., Dehnad, A., Shanehbandi, D., Mohamed Khosroshahi, L., & Aghapour, M. (2016). The immunomodulatory activity of secondary metabolites isolated from Streptomyces calvus on human peripheral blood mononuclear cells. British Journal of Biomedical Science.

Khandan Nasab, N., Dehnad, A. R., Salimizand, H., Taherzadeh, D., Prakash, D., Verma, K. D., & Darroudi, M. (2016). Zinc selenide nanoparticles (ZnSe-NPs): Green synthesis and investigation of their cytotoxicity effects. Ceramics International.

Dehnad, A., Hamedi, J., Derakhshan-Khadivi, F., & Abusov, R. (2015). Green synthesis of gold nanoparticles by a metal resistant Arthrobacter nitroguajacolicus isolated from gold mine. IEEE Transactions on Nanobioscience.

Sadighbayan, K., Dehnad, A., Monadi, A., Mobaiyen, H., & Sadighbayan, D. (2013). An evaluation about the role of microorganisms isolated from the soil in the biological removal of toxic petroleum pollutants. Journal of Environmental Studies.

Sadigh-Eteghad, S., Dehnad, A., Mahmodi, J., Hoseyni, H., Khalili, I., & Razmaray II, N. (2013). Healing potential of a Streptomyces sp. secondary metabolite, SEM-1-111, on experimental full-thickness excision cutaneous wounds in Wistar rats. Clinical and Experimental Dermatology.

Himanshi Yaduvanshi | Onco-Immunology | Best Researcher Award

Dr. Himanshi Yaduvanshi | Onco-Immunology | Best Researcher Award

Springer Nature | India

Dr. Himanshi Yaduvanshi is a PhD-trained life sciences researcher with strong expertise in oncology, immunology, and metabolic disorders, specializing in the interplay between glucose and lipid metabolism and cancer progression. Her research contributions span mechanistic studies in melanoma, breast cancer, and colon cancer, with a particular focus on metabolic reprogramming, macrophage phenotypic switching in obesity-linked tumor growth, and therapeutic modulation of cholesterol pathways. She has published several peer-reviewed research articles in respected journals such as Cancer Research, Cancer Metabolism, Molecular Cell Research, and Journal of Biosciences, in addition to contributing to preprints and collaborative manuscripts currently in preparation. Her work is further strengthened by involvement in an Indian patent on a novel anticancer therapeutic combination, demonstrating her commitment to translational innovation. Dr. Yaduvanshi’s technical proficiency encompasses flow cytometry, confocal microscopy, in vivo tumor models, metabolic assays using Seahorse technology, immunophenotyping, molecular cloning, qPCR, immunoblotting, and proteomics workflows. Her research background is distinguished by effective collaboration across multidisciplinary teams at the National Centre for Cell Science (NCCS), where she led experimental design, troubleshooting, and data analysis for complex, multi-lab projects. She has participated in national and international scientific platforms, presenting her work at the International Union of Immunological Societies (IUIS) Conference, CMBC Conference, and Immuno-Oncology Society of India (I-OSI), earning recognition for both poster and oral presentations. Beyond academic research, Dr. Yaduvanshi contributes to scientific communication and industry engagement through her roles as Technical Sales Manager at Bio Bench Solutions and Associate Editor with Springer Nature, where she ensures the quality and integrity of scientific protocols. Her work collectively supports societal impact by advancing understanding of cancer metabolism and informing the development of more effective therapeutic strategies. With a strong record of research excellence, innovation, and interdisciplinary collaboration, Dr. Yaduvanshi continues to contribute meaningfully to global biomedical science.

Profile: ORCID

Featured Publications

  1. Athavale, D., Yaduvanshi, H., Bhati, F. K., Mayengbam, S. S., More, T., Rapole, S., & Bhat, M. K. (2024). Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment.
  2. Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023). Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells. Cancer & Metabolism, 11.
  3. Singh, A., Mayengbam, S. S., Yaduvanshi, H., Wani, M. R., & Bhat, M. K. (2022). Obesity programs macrophages to support cancer progression. Cancer Research, 82.

Honghui Tang | Immunology and Microbiology | Best Researcher Award

Mrs. Honghui Tang | Immunology and Microbiology | Best Researcher Award

Deputy Chief Technician from Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, China

Honghui Tang is an experienced clinical laboratory professional currently serving as the Associate Chief Technician and Supervisor of Clinical Biochemistry at the Clinical Testing Center of the Fourth Affiliated Hospital of Soochow University. With over 21 years of specialized experience, she has developed in-depth expertise in clinical biochemistry and immunological testing. Her career is distinguished by her focus on quality management, laboratory standardization, and diagnostic excellence. She plays a key role in implementing the ISO 15189 accreditation system, designing and enforcing SOP frameworks, and ensuring efficient, accurate, and compliant laboratory operations. Tang is proficient in handling a variety of automated biochemical and immunoassay analyzers and leads the end-to-end diagnostic process. She is also deeply involved in interdepartmental collaboration to resolve complex diagnostic challenges and improve patient care outcomes. As a recognized professional, she serves as a member of the Clinical Biochemistry and Immunology Committee under the Laboratory Medicine Branch of the Suzhou Medical Association. Her leadership, technical competence, and commitment to healthcare advancement position her as a notable contributor in the field of laboratory medicine. While her focus has been more practice-oriented, she remains committed to expanding her engagement with research and evidence-based diagnostics.

Professional Profile

Education

Although the exact educational qualifications are not listed, it is evident that Honghui Tang has undergone advanced academic and professional training to attain the level of Associate Chief Technician in a prestigious clinical setting. Achieving such a role requires a strong educational foundation in clinical laboratory sciences, likely including a bachelor’s degree in Medical Laboratory Technology, Clinical Biochemistry, or a related field, followed by further specialization or advanced diplomas in laboratory diagnostics and quality management systems. Additionally, her ability to lead ISO 15189 implementation efforts and develop comprehensive SOP frameworks suggests extensive continuing education and training in laboratory accreditation protocols, biochemistry techniques, and health sciences management. Such a background is typically supplemented by practical hospital-based internships and certifications in biochemical and immunoassay technologies. As she operates in a university hospital setting and holds a supervisory position, it is also likely that she has participated in professional development programs offered by medical associations and institutional training initiatives. Her academic and technical education has enabled her to navigate complex diagnostic environments while ensuring quality, efficiency, and clinical accuracy.

Professional Experience

Honghui Tang brings over two decades of distinguished professional experience in clinical laboratory medicine, with her current role as Supervisor of Clinical Biochemistry at the Fourth Affiliated Hospital of Soochow University. She has been instrumental in shaping the operational standards of the Clinical Testing Center by implementing quality systems that align with international benchmarks, including ISO 15189. Her core responsibilities span the entire testing process—pre-analytical, analytical, and post-analytical phases—ensuring seamless workflow, error minimization, and clinical reliability. Tang is responsible for managing a wide array of automated instruments, including biochemical and immunoassay analyzers from leading manufacturers. She supervises equipment calibration, maintenance, and troubleshooting, guaranteeing uninterrupted laboratory operations. Her role demands daily interaction with clinicians, which she fulfills by advising on complex test results and refining diagnostic workflows. As a senior member of the laboratory, she also mentors junior staff, conducts training sessions, and enforces strict compliance with established standard operating procedures. Beyond the laboratory setting, she contributes to the broader medical community through her role on the Clinical Biochemistry and Immunology Committee of the Suzhou Medical Association. This combination of technical mastery and leadership underscores her status as a key pillar in her institution’s diagnostic excellence.

Research Interests

While Honghui Tang’s primary expertise lies in clinical laboratory practice, her work intersects significantly with applied research in diagnostic standardization and quality assurance. Her key research interests include the development and validation of diagnostic protocols in clinical biochemistry, the optimization of laboratory workflows for enhanced accuracy, and the implementation of ISO 15189 standards in clinical settings. She is also deeply invested in exploring strategies for minimizing analytical variability, increasing inter-laboratory result harmonization, and improving diagnostic turnaround time. Another area of interest is the clinical interpretation of immunological assay results in complex or ambiguous patient cases, especially in collaborative efforts with physicians for evidence-based medical decision-making. Her contributions have practical implications for diagnostic reliability and healthcare delivery, and her engagement with hospital-wide interdisciplinary case reviews presents unique opportunities for applied clinical research. With the right collaborations, she is well-positioned to contribute to scholarly work on laboratory accreditation, test performance evaluation, and diagnostic technology integration in modern hospital settings. As she continues her career, these research interests could be further developed through collaborative publications, quality improvement studies, and clinical trials focused on diagnostic biomarkers.

Research Skills

Honghui Tang possesses a wide range of advanced research skills rooted in clinical laboratory practice. She is highly proficient in operating and maintaining a variety of automated biochemical and immunoassay analyzers, which is essential for both diagnostic accuracy and research application. Her strengths include data quality management, implementation of international quality standards like ISO 15189, and development of laboratory standard operating procedures (SOPs)—key competencies that support research reproducibility and methodological rigor. Tang also brings expertise in analytical troubleshooting and validation of test results, including root-cause analysis for irregular findings. She is adept in documenting diagnostic workflows, preparing laboratory reports, and contributing to interdepartmental discussions to resolve complex cases. These practical experiences have equipped her with strong skills in data interpretation, assay performance monitoring, and evidence-based evaluation. Additionally, her work supervising other technicians and managing laboratory systems underscores her project management, documentation, and training abilities. Although she has yet to publish widely, her operational expertise provides a strong foundation for translational research and diagnostic innovation. Her technical fluency, especially in relation to test automation and quality assurance, makes her well-prepared to contribute to applied clinical research and collaborative investigations.

Awards and Honors

While no specific awards or honors are mentioned in the available information, Honghui Tang’s appointment as Associate Chief Technician and her leadership role in one of Soochow University’s affiliated hospitals are significant recognitions of her professional contributions. The trust placed in her to lead the Clinical Biochemistry section, oversee quality assurance, and implement accreditation standards such as ISO 15189 attests to her high level of competence and dedication. Furthermore, her selection as a committee member of the Clinical Biochemistry and Immunology Division of the Suzhou Medical Association reflects professional acknowledgment by her peers and industry leaders. These roles typically require demonstrated excellence in laboratory management, technical proficiency, and consistent contribution to healthcare services. Although formal honors such as national or international research awards are not listed, her career achievements indicate that she has earned institutional and professional respect. As she continues to engage more actively in research, particularly through collaborations and publications, she stands to receive additional recognition at the academic and scientific levels in the near future.

Conclusion

Honghui Tang exemplifies excellence in clinical laboratory science through her extensive experience, leadership, and technical acumen. Her 21-year career is marked by a commitment to diagnostic precision, quality management, and the continuous advancement of clinical laboratory operations. As Associate Chief Technician, she plays a pivotal role in standardizing procedures, implementing internationally recognized accreditation systems, and training new professionals. Her ability to operate across technical, managerial, and clinical dimensions makes her a vital contributor to patient care and hospital diagnostics. While her work is largely practice-oriented, she possesses a strong foundation for research, particularly in diagnostic standardization and quality assurance. Moving forward, increased participation in academic research and publication will enhance her professional profile and contribute to the scientific community. With her established expertise, leadership roles, and interest in applied research, Honghui Tang is a highly deserving candidate for the Best Researcher Award in the field of clinical laboratory science. Her work not only improves operational outcomes but also ensures the accuracy and integrity of patient diagnostics, reflecting the critical role of laboratory science in modern healthcare.